CEO: Manny Krakaris
Headquarters: San Francisco, California
URL: www.augmedix.com
October 2020
APO Financing: $25,000,000

(Acquired in July 2024 for $139 Million by Commure, Inc.)
Trading Venue: NASDAQ CM (AUGX) Acquired

Augmedix converts natural clinician-patient conversation into medical documentation and provides live support, including referrals, orders, and reminders, so clinicians can focus on what matters most: patient care.

The Augmedix platform is powered by a combination of proprietary automation modules and human-expert assistants operating in HIPAA-secure locations to generate accurate, comprehensive, and timely-delivered medical documentation.

Augmedix services are compatible with over 35 specialties and are trusted by over one dozen American health systems supporting telemedicine, medical offices, clinics, and hospitals.  We estimate that our solution saves clinicians 2–3 hours per day, increases productivity by as much as 20%, and increases certain clinicians’ satisfaction with work-life balance by 49%.

INVESTORS

COMPANIES WE HAVE FUNDED